Cargando…
Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions
BACKGROUND: Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408044/ https://www.ncbi.nlm.nih.gov/pubmed/37553603 http://dx.doi.org/10.1186/s40900-023-00479-6 |
_version_ | 1785086097231970304 |
---|---|
author | Elfassy, Caroline Wagner, Lisa Higgins, Johanne Montpetit, Kathleen Snider, Laurie Dahan-Oliel, Noémi |
author_facet | Elfassy, Caroline Wagner, Lisa Higgins, Johanne Montpetit, Kathleen Snider, Laurie Dahan-Oliel, Noémi |
author_sort | Elfassy, Caroline |
collection | PubMed |
description | BACKGROUND: Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives and involvement is a crucial and necessary step. This study sought to determine the most clinically useful items for an outcome measure of UE function for children with AMC as defined by caregivers and clinicians. METHODS: To ensure the perspectives and needs of caregivers of children with AMC and clinicians were considered in the development of the UE measure for AMC, a Nominal Group technique (NGT) with caregivers of children with AMC (phase 1) followed by a three-round survey with clinicians (phase 2) were carried out. RESULTS: Phase 1: Eleven individuals participated in the nominal group technique and identified 32 items. The most important items were Picking up an object (n = 11), Eating (n = 10), Reaching mouth (n = 10), Getting out of bed (n = 10). Phase 2: Invitations to participate to an online survey was sent to 47 experts in the field of AMC, 20 participants completed round 1, 15 completed round 2 and 13 completed round 3. Throughout the survey, participants were asked about movement required to screen the UE, essential domains to be included in the measure, establishing a scoring guide and identifying tasks associated with joint motion and position. CONCLUSION: A preliminary version of an UE AMC-specific outcome measure was developed with the help of caregivers’ perspectives and expert opinions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00479-6. |
format | Online Article Text |
id | pubmed-10408044 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104080442023-08-09 Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions Elfassy, Caroline Wagner, Lisa Higgins, Johanne Montpetit, Kathleen Snider, Laurie Dahan-Oliel, Noémi Res Involv Engagem Research BACKGROUND: Upper extremity (UE) involvement is prevalent in 73% of individuals with arthrogryposis multiplex congenita (AMC), yet no AMC-specific outcome measure exists. When developing a measure specific to a population with a rare musculoskeletal condition, clinicians’ and patients’ perspectives and involvement is a crucial and necessary step. This study sought to determine the most clinically useful items for an outcome measure of UE function for children with AMC as defined by caregivers and clinicians. METHODS: To ensure the perspectives and needs of caregivers of children with AMC and clinicians were considered in the development of the UE measure for AMC, a Nominal Group technique (NGT) with caregivers of children with AMC (phase 1) followed by a three-round survey with clinicians (phase 2) were carried out. RESULTS: Phase 1: Eleven individuals participated in the nominal group technique and identified 32 items. The most important items were Picking up an object (n = 11), Eating (n = 10), Reaching mouth (n = 10), Getting out of bed (n = 10). Phase 2: Invitations to participate to an online survey was sent to 47 experts in the field of AMC, 20 participants completed round 1, 15 completed round 2 and 13 completed round 3. Throughout the survey, participants were asked about movement required to screen the UE, essential domains to be included in the measure, establishing a scoring guide and identifying tasks associated with joint motion and position. CONCLUSION: A preliminary version of an UE AMC-specific outcome measure was developed with the help of caregivers’ perspectives and expert opinions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00479-6. BioMed Central 2023-08-08 /pmc/articles/PMC10408044/ /pubmed/37553603 http://dx.doi.org/10.1186/s40900-023-00479-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Elfassy, Caroline Wagner, Lisa Higgins, Johanne Montpetit, Kathleen Snider, Laurie Dahan-Oliel, Noémi Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions |
title | Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions |
title_full | Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions |
title_fullStr | Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions |
title_full_unstemmed | Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions |
title_short | Stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions |
title_sort | stakeholder engagement in the development of an upper extremity outcome measure for children with rare musculoskeletal conditions |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408044/ https://www.ncbi.nlm.nih.gov/pubmed/37553603 http://dx.doi.org/10.1186/s40900-023-00479-6 |
work_keys_str_mv | AT elfassycaroline stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions AT wagnerlisa stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions AT higginsjohanne stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions AT montpetitkathleen stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions AT sniderlaurie stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions AT dahanolielnoemi stakeholderengagementinthedevelopmentofanupperextremityoutcomemeasureforchildrenwithraremusculoskeletalconditions |